Skip to main content

Direct-to-implant or two-stage breast reconstruction in pathogenic mutations carriers after risk-reducing nipple-sparing mastectomy: A real-world multicenter cohort

In brief

Direct-to-implant reconstruction had fewer contractures than tissue expanders

In this retrospective study of 523 patients with pathogenic mutations, capsular contracture occurred in 7.0% with direct-to-implant reconstruction versus 18.4% with tissue expanders; early complications were similar at about 1 in 5. Aesthetic outcomes also favored direct-to-implant, but assessments were not blinded, so the apparent advantage needs cautious interpretation.

Journal
Journal of plastic, reconstructive & aesthetic surgery : JPRAS (Q1)
Published
29 October 2026
Study design
Retrospective cohort
Evidence level
Level 3, Low (CEBM 3b)
Authors
Francisco Pimentel Cavalcante, Marcelo Antonini, Antonio Luiz Frasson, Idam de Oliveira-Junior, Fabricio P Brenelli, Anastasio Berrettini Junior, et al.
PMID
43019623
DOI
10.1016/j.bjps.2026.10.038

Why clinicians should know about it

  • Picked for Breast and Endocrine Surgery (paper of the day, 14 November 2026): Direct-to-implant versus expander reconstruction after risk-reducing mastectomy

Abstract

BACKGROUND: Nipple-sparing mastectomy (NSM) with immediate implant-based reconstruction has become a preferred strategy for patients with pathogenic germline variant (PV) undergoing risk-reducing mastectomy (RRM). However, the optimal reconstructive approach-whether direct-to-implant (DTI) or tissue expander (TE)-continues to be controversial. METHODS: This retrospective multicenter cohort study included patients with PVs who underwent NSM with implant-based reconstruction (2008-2025). Patients were grouped according to reconstruction type (DTI vs. TE). Outcomes included early postoperative complications, capsular contracture (Baker grade III), additional reconstructive surgeries, and aesthetic outcomes. Inverse probability of treatment weighting (IPTW) based on propensity scores was used as the primary analysis. RESULTS: A total of 523 patients (742 breasts) were included: 447 (85.5%) underwent DTI reconstruction and 76 (14.5%) underwent TE reconstruction. Baseline characteristics were comparable. Early complications did not differ significantly (19.0% vs. 21.1%; p=0.64). TE reconstruction was found to be associated with higher capsular contracture (18.4% vs. 7.0%; p=0.003) and worse aesthetic outcomes (76.7% vs. 91.7%; p=0.002). In the primary IPTW-weighted analysis (multiple imputation, m=20), TE was found to be independently associated with increased capsular contracture (weighted OR 3.69; 95% CI 1.74-7.83; p=0.001; absolute risk difference +15.1%) and lower likelihood of favorable aesthetic outcome (weighted OR 0.32; 95% CI 0.14-0.72; p=0.006; absolute risk difference -14.3%); these findings were found to be consistent in conventional multivariable and sensitivity analyses. CONCLUSIONS: DTI reconstruction was not associated with increased early complications and it was independently associated with lower capsular contracture than TE and it trended toward better aesthetic outcomes; however, this warrants cautious interpretation given non-blinded assessment. DTI appears to be safe and effective in appropriately selected patients.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.